Thyroid MALT Lymphoma: Self-Harm to Gain Potential T-cell Help.
Fangtian Wu,Natsuko Watanabe,Maria-Myrsini Tzioni,Ayse Akarca,Chunye Zhang,Yan Li,Zi Chen,Francesco Cucco,Natasha Carmell,Jaeduk Yoshimura Noh,Koichi Ito,Rachel Dobson,Sarah Moody,Wenqing Yao,Wenyan Zhang,Weiping Liu,Hongxiang Liu,Jessica Okosun,Andreas Chott,Yingwen Bi,Shih-Sung Chuang,Markus Raderer,Jian-Yong Li,Teresa Marafioti,Ming-Qing Du
DOI: https://doi.org/10.1038/s41375-021-01289-z
2021-01-01
Leukemia
Abstract:The development of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is driven by chronic inflammatory responses and acquired genetic changes. To investigate its genetic bases, we performed targeted sequencing of 93 genes in 131 MALT lymphomas including 76 from the thyroid. We found frequent deleterious mutations of TET2 (86%), CD274 (53%), TNFRSF14 (53%), and TNFAIP3 (30%) in thyroid MALT lymphoma. CD274 was also frequently deleted, together with mutation seen in 68% of cases. There was a significant association between CD274 mutation/deletion and TNFRSF14 mutation ( p = 0.001). CD274 (PD-L1) and TNFRSF14 are ligands for the co-inhibitory receptor PD1 and BTLA on T-helper cells, respectively, their inactivation may free T-cell activities, promoting their help to malignant B-cells. In support of this, both the proportion of activated T-cells (CD4+CD69+/CD4+) within the proximity of malignant B-cells, and the level of transformed blasts were significantly higher in cases with CD274 / TNFRSF14 genetic abnormalities than those without these changes. Both CD274 and TNFRSF14 genetic changes were significantly associated with Hashimoto’s thyroiditis ( p = 0.01, p = 0.04, respectively), and CD274 mutation/deletion additionally associated with increased erythrocyte sedimentation rate ( p = 0.0001). In conclusion, CD274 / TNFRSF14 inactivation in thyroid MALT lymphoma B-cells may deregulate their interaction with T-cells, promoting co-stimulations and impairing peripheral tolerance.